EFFICACY OF AEROSOLIZED LIPOSOMAL AMPHOTERICIN-B (AMBISOME(R)) AS A PROPHYLACTIC TREATMENT IN AN IMMUNE COMPROMISED MURINE MODEL OF PULMONARY ASPERGILLOSIS

被引：5
|
作者：
ALLEN, SD [1 ]
SORENSEN, KN [1 ]
NEJDL, MJ [1 ]
PROFFITT, RT [1 ]
机构：
[1] VESTAR INC,SAN DIMAS,CA 91773
来源：
JOURNAL OF CONTROLLED RELEASE | 1994年 / 28卷 / 1-3期
关键词：
D O I：
10.1016/0168-3659(94)90210-0
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：348 / 349
页数：2
相关论文
共 50 条
  • [1] PROPHYLACTIC EFFICACY OF AEROSOLIZED LIPOSOMAL (AMBISOME) AND NON-LIPOSOMAL (FUNGIZONE) AMPHOTERICIN-B IN MURINE PULMONARY ASPERGILLOSIS
    ALLEN, SD
    SORENSEN, KN
    NEJDL, MJ
    DURRANT, C
    PROFFIT, RT
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (06) : 1001 - 1013
  • [2] COMPARISON OF A LIPOSOMAL AMPHOTERICIN-B FORMULATION (AMBISOME) AND DEOXYCHOLATE AMPHOTERICIN-B (FUNGIZONE) FOR THE TREATMENT OF MURINE PARACOCCIDIOIDOMYCOSIS
    CLEMONS, KV
    STEVENS, DA
    [J]. JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1993, 31 (05): : 387 - 394
  • [3] THERAPEUTIC EFFICACY OF A LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) AGAINST MURINE BLASTOMYCOSIS
    CLEMONS, KV
    STEVENS, DA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (03) : 465 - 472
  • [4] TREATMENT OF MURINE CANDIDOSIS AND CRYPTOCOCCOSIS WITH A UNILAMELLAR LIPOSOMAL AMPHOTERICIN-B FORMULATION (AMBISOME)
    ADLERMOORE, JP
    CHIANG, SM
    SATORIUS, A
    GUERRA, D
    MCANDREWS, B
    MCMANUS, EJ
    PROFFITT, RT
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 : 63 - 71
  • [5] AEROSOLIZATION OF LIPOSOMAL (AMBISOME(R)) AND NON-LIPOSOMAL (FUNGIZONE(R)) AMPHOTERICIN-B AS A TREATMENT FOR PULMONARY FUNGAL-INFECTIONS
    SORENSEN, KN
    ALLEN, SD
    NEJDL, MJ
    PROFFITT, RT
    [J]. JOURNAL OF CONTROLLED RELEASE, 1994, 28 (1-3) : 346 - 347
  • [6] Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats
    Ruijgrok, EJ
    Vulto, AG
    Van Etten, EWM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (01) : 89 - 95
  • [7] STABILITY AND MODE OF ACTION OF AMBISOME(R) (LIPOSOMAL AMPHOTERICIN-B)
    PROFFITT, RT
    ADLERMOORE, J
    FUJII, G
    SATORIUS, A
    LEE, MJA
    BAILEY, A
    [J]. JOURNAL OF CONTROLLED RELEASE, 1994, 28 (1-3) : 342 - 343
  • [8] Comparative Study on the Efficacy of Liposomal Amphotericin B and Voriconazole in a Murine Pulmonary Aspergillosis Model
    Takemoto, Koji
    Yamamoto, Yutaka
    Ueda, Yutaka
    Kanazawa, Katsunori
    Yoshida, Koichiro
    Niki, Yoshihito
    [J]. CHEMOTHERAPY, 2009, 55 (02): : 105 - 113
  • [9] Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis
    Mihara, Tomo
    Kakeya, Hiroshi
    Izumikawa, Koichi
    Obata, Yoko
    Nishino, Tomoya
    Takazono, Takahiro
    Kosai, Kosuke
    Morinaga, Yoshitomo
    Kurihara, Shintaro
    Nakamura, Shigeki
    Imamura, Yoshifumi
    Miyazaki, Taiga
    Tsukamoto, Misuzu
    Yamamoto, Yoshihiro
    Yanagihara, Katsunori
    Tashiro, Takayoshi
    Kohno, Shigeru
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (1-2) : 104 - 108
  • [10] Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
    Sofie Van Ackerbroeck
    Lynn Rutsaert
    Ella Roelant
    Kathleen Dillen
    Joost Wauters
    Niels Van Regenmortel
    [J]. Critical Care, 25
12345